Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen

Aninda Basu, Indranil Basu, Aruna Chakraborty, Soumitro Pal, Utpala Chattopadhyay

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A male breast tumor associated antigen (MBTAA) was purified and partially characterized from human male breast tumor. Three protein peaks were obtained by DEAE-cellulose column chromatography of a crude extract of human male breast tumor tissues. Circulating antibodies against one of these peaks, MFI, which contained MBTAA, were observed in male breast cancer patients but not in normal male or male patients with carcinoma of other organs (stomach, colon, lung). The MBTAA was partially purified from MFI by subjecting the fraction to SDS-PAGE and eluting the protein from band 3 (MB-3) and by subjecting MFI to size exclusion-high performance liquid chromatography (SE-HPLC). The MBTAA was characterized as a glycoprotein with MW of approximately 72 kDa. It showed no immunological relatedness with TAG-72, a tumor associated antigen expressed in breast epithelial cells. A 72 kDa protein, immunologically related to MBTAA, was detected and partially purified from female breast tumor. The female breast cancer patients did not have circulating antibodies against this 72 kDa protein or MBTAA. Presence of 72 kDa glycoprotein MBTAA in MFI and specificity of the anti-MBTAA antibodies in the sera of male breast cancer patients were further confirmed by Western blot analysis. Absence of anti-MBTAA antibodies in healthy men and in patients with other cancers suggested that expression of MBTAA may be malignancy-associated and is highly overexpressed in male breast cancer.

Original languageEnglish (US)
Pages (from-to)377-383
Number of pages7
JournalInternational Journal of Cancer
Volume105
Issue number3
DOIs
StatePublished - Jun 20 2003
Externally publishedYes

Fingerprint

Male Breast Neoplasms
Neoplasm Antigens
Glycoproteins
Antibodies
Far-Western Blotting
Erythrocyte Anion Exchange Protein 1
Breast Neoplasms
DEAE-Cellulose Chromatography
Proteins

Keywords

  • Breast tumor associated antigen
  • Male breast tumor
  • TAG-72

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen. / Basu, Aninda; Basu, Indranil; Chakraborty, Aruna; Pal, Soumitro; Chattopadhyay, Utpala.

In: International Journal of Cancer, Vol. 105, No. 3, 20.06.2003, p. 377-383.

Research output: Contribution to journalArticle

Basu, Aninda ; Basu, Indranil ; Chakraborty, Aruna ; Pal, Soumitro ; Chattopadhyay, Utpala. / Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen. In: International Journal of Cancer. 2003 ; Vol. 105, No. 3. pp. 377-383.
@article{efdffc4cd23749379985d241f5572fb8,
title = "Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen",
abstract = "A male breast tumor associated antigen (MBTAA) was purified and partially characterized from human male breast tumor. Three protein peaks were obtained by DEAE-cellulose column chromatography of a crude extract of human male breast tumor tissues. Circulating antibodies against one of these peaks, MFI, which contained MBTAA, were observed in male breast cancer patients but not in normal male or male patients with carcinoma of other organs (stomach, colon, lung). The MBTAA was partially purified from MFI by subjecting the fraction to SDS-PAGE and eluting the protein from band 3 (MB-3) and by subjecting MFI to size exclusion-high performance liquid chromatography (SE-HPLC). The MBTAA was characterized as a glycoprotein with MW of approximately 72 kDa. It showed no immunological relatedness with TAG-72, a tumor associated antigen expressed in breast epithelial cells. A 72 kDa protein, immunologically related to MBTAA, was detected and partially purified from female breast tumor. The female breast cancer patients did not have circulating antibodies against this 72 kDa protein or MBTAA. Presence of 72 kDa glycoprotein MBTAA in MFI and specificity of the anti-MBTAA antibodies in the sera of male breast cancer patients were further confirmed by Western blot analysis. Absence of anti-MBTAA antibodies in healthy men and in patients with other cancers suggested that expression of MBTAA may be malignancy-associated and is highly overexpressed in male breast cancer.",
keywords = "Breast tumor associated antigen, Male breast tumor, TAG-72",
author = "Aninda Basu and Indranil Basu and Aruna Chakraborty and Soumitro Pal and Utpala Chattopadhyay",
year = "2003",
month = "6",
day = "20",
doi = "10.1002/ijc.11061",
language = "English (US)",
volume = "105",
pages = "377--383",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen

AU - Basu, Aninda

AU - Basu, Indranil

AU - Chakraborty, Aruna

AU - Pal, Soumitro

AU - Chattopadhyay, Utpala

PY - 2003/6/20

Y1 - 2003/6/20

N2 - A male breast tumor associated antigen (MBTAA) was purified and partially characterized from human male breast tumor. Three protein peaks were obtained by DEAE-cellulose column chromatography of a crude extract of human male breast tumor tissues. Circulating antibodies against one of these peaks, MFI, which contained MBTAA, were observed in male breast cancer patients but not in normal male or male patients with carcinoma of other organs (stomach, colon, lung). The MBTAA was partially purified from MFI by subjecting the fraction to SDS-PAGE and eluting the protein from band 3 (MB-3) and by subjecting MFI to size exclusion-high performance liquid chromatography (SE-HPLC). The MBTAA was characterized as a glycoprotein with MW of approximately 72 kDa. It showed no immunological relatedness with TAG-72, a tumor associated antigen expressed in breast epithelial cells. A 72 kDa protein, immunologically related to MBTAA, was detected and partially purified from female breast tumor. The female breast cancer patients did not have circulating antibodies against this 72 kDa protein or MBTAA. Presence of 72 kDa glycoprotein MBTAA in MFI and specificity of the anti-MBTAA antibodies in the sera of male breast cancer patients were further confirmed by Western blot analysis. Absence of anti-MBTAA antibodies in healthy men and in patients with other cancers suggested that expression of MBTAA may be malignancy-associated and is highly overexpressed in male breast cancer.

AB - A male breast tumor associated antigen (MBTAA) was purified and partially characterized from human male breast tumor. Three protein peaks were obtained by DEAE-cellulose column chromatography of a crude extract of human male breast tumor tissues. Circulating antibodies against one of these peaks, MFI, which contained MBTAA, were observed in male breast cancer patients but not in normal male or male patients with carcinoma of other organs (stomach, colon, lung). The MBTAA was partially purified from MFI by subjecting the fraction to SDS-PAGE and eluting the protein from band 3 (MB-3) and by subjecting MFI to size exclusion-high performance liquid chromatography (SE-HPLC). The MBTAA was characterized as a glycoprotein with MW of approximately 72 kDa. It showed no immunological relatedness with TAG-72, a tumor associated antigen expressed in breast epithelial cells. A 72 kDa protein, immunologically related to MBTAA, was detected and partially purified from female breast tumor. The female breast cancer patients did not have circulating antibodies against this 72 kDa protein or MBTAA. Presence of 72 kDa glycoprotein MBTAA in MFI and specificity of the anti-MBTAA antibodies in the sera of male breast cancer patients were further confirmed by Western blot analysis. Absence of anti-MBTAA antibodies in healthy men and in patients with other cancers suggested that expression of MBTAA may be malignancy-associated and is highly overexpressed in male breast cancer.

KW - Breast tumor associated antigen

KW - Male breast tumor

KW - TAG-72

UR - http://www.scopus.com/inward/record.url?scp=0037882108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037882108&partnerID=8YFLogxK

U2 - 10.1002/ijc.11061

DO - 10.1002/ijc.11061

M3 - Article

VL - 105

SP - 377

EP - 383

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -